Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05610020

Heparin Binding Protein as a Prognostic Biomarker of Sepsis Severity

Conditions: Sepsis, HBP

Sex: All
Ages: 20 Years – 70 Years
Enrollment: 55
Sponsor: Ain Shams University

Location: Egypt

Summary

the aim of the study is to correlate between the severity of sepsis and serum heparin binding protein in the patients admitted to ICU with sepsis., and detect its value as a prognostic biomarker in sepsis

Eligibility Criteria

Inclusion Criteria:adult whose age between 20 to70 years oldpatients suffered from sepsis or septic shock (under the third international consensus definition of sepsis and septic shock)Exclusion Criteria:Any pregnancy femaleAny patient who is Neutropenic secondary to malignancyPatients who is taking immunosuppressive therapyPatients who is suffering fromHematological malignancy

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05610020). StuddyBuddy aggregates publicly available trial information.